Identification of differentially expressed proteins in spontaneous thymic lymphomas from knockout mice with deletion of p53

Proteome Science

Volumn 6, Issue , 2008, Pages

  Honoré, Bent ^a   Buus, Søren ^b   Claësson, Mogens H ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

25 KDA ACTIN FRAGMENT; ACIDIC COFILIN 1 VARIANT; ACTIN RELATED PROTEIN; ADENYLOSUCCINATE SYNTHASE; BASIC COFILIN 1 VARIANT; BETA TUBULIN; COFILIN 1; EPIDERMAL FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN; GLIA MATURATION FACTOR; GLIA MATURATION FACTOR GAMMA; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; MITOCHONDRIAL ORNITHINE AMINOTRANSFERASE; ORNITHINE OXOACID AMINOTRANSFERASE; PROTEASOME; PROTEASOME SUBUNIT ALPHA TYPE 3; PROTEASOME SUBUNIT BETA TYPE 9; PROTEIN P53; RHO GDP DISSOCIATION INHIBITOR 2; TRANSFORMING ACID COILED COIL CONTAINING PROTEIN 3; TRANSFORMING PROTEIN; TUBULIN BETA 3 CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; GENE DELETION; KNOCKOUT MOUSE; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; TANDEM MASS SPECTROMETRY; THYMOCYTE; THYMUS LYMPHOMA; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WILD TYPE;

MUS;

EID: 48649095492     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-6-18     Document Type: Article

References (39)

1. Offringa R Vierboom MP Burg van der SH Erdile L Melief CJ p53: A potential target antigen for immunotherapy of cancer Ann N Y Acad Sci 2000, 910:223-233. discussion 233-226. 10911916
2. Eliyahu D Raz A Gruss P Givol D Oren M Participation of p53 cellular tumour antigen in transformation of normal embryonic cells Nature 1984, 312:646-649. 10.1038/312646a0 6095116
3. Matlashewski G Banks L Pim D Crawford L Analysis of human p53 proteins and mRNA levels in normal and transformed cells Eur J Biochem 1986, 154:665-672. 10.1111/j.1432-1033.1986.tb09449.x 2419131
4. Lane DP Benchimol S p53: Oncogene or anti-oncogene? Genes Dev 1990, 4:1-8. 10.1101/gad.4.1.1 2137806
5. Hollstein M Sidransky D Vogelstein B Harris CC p53 mutations in human cancers Science 1991, 253:49-53. 10.1126/science.1905840 1905840
6. Caron de Fromentel C Soussi T TP53 tumor suppressor gene: A model for investigating human mutagenesis Genes Chromosomes Cancer 1992, 4:1-15. 10.1002/gcc.2870040102 1377002
7. Wang XW Role of p53 and apoptosis in carcinogenesis Anticancer Res 1999, 19:4759-4771. 10697590
8. Mathiassen S Lauemoller SL Ruhwald M Claësson MH Buus S Tumor-associated antigens identified by mRNA expression profiling induce protective anti-tumor immunity Eur J Immunol 2001, 31;1239-1246. 10.1002/ 1521-4141(200104)31:4<1239::AID-IMMU1239>3.0.CO;2-C 11298350
9. Andersen ML Ruhwald M Thorn M Pedersen AE Mathiassen S Buus S Claësson MH Tumor-associated antigens identified by mRNA expression profiling as tumor rejection epitopes J Immune Based Ther Vaccines 2003, 1:1. 153425 12709261 10.1186/1476-8518-1-1
10. Honoré B Vorum H Pedersen AE Buus S Claësson MH Changes in protein expression in p53 deleted spontaneous thymic lymphomas Exp Cell Res 2004, 295:91-101. 10.1016/j.yexcr.2003.11.029 15051493
11. Honoré B Østergaard M Vorum H Functional genomics studied by proteomics Bioessays 2004, 26:901-915. 10.1002/bies.20075 15273992
12. Hosaka M Toda K Takatsu H Torii S Murakami K Nakayama K Structure and intracellular localization of mouse ADP-ribosylation factors type 1 to type 6 (ARF1-ARF6) J Biochem 1996, 120(4):813-819. 8947846
13. Hemmings BA Adams-Pearson C Maurer F Muller P Goris J Merlevede W Hofsteenge J Stone SR alpha- and beta-forms of the 65-kDa subunit of protein phosphatase 2A have a similar 39 amino acid repeating structure Biochemistry 1990, 29:3166-3173. 10.1021/bi00465a002 2159327
14. Wu W Tang X Hu W Lotan R Hong WK Mao L Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry Clin Exp Metastasis 2002, 19:319-326. 10.1023/A:1015515119300 12090472
15. Chuthapisith S Layfield R Kerr ID Hughes C Eremin O Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs Int J Oncol 2007, 30:1545-1551. 17487377
16. Nakamura Y Isolation of p53-target genes and their functional analysis Cancer Sci 2004, 95:7-11. 10.1111/j.1349-7006.2004.tb03163.x 14720320
17. Harris SL Levine AJ The p53 pathway: Positive and negative feedback loops Oncogene 2005, 24:2899-2908. 10.1038/sj.onc.1208615 15838523
18. Shu KX Li B Wu LX The p53 network: P53 and its downstream genes Colloids Surf B Biointerfaces 2007, 55:10-18. 10.1016/j.colsurfb.2006.11.003 17188467
19. Comer KA Dennis PA Armstrong L Catino JJ Kastan MB Kumar CC Human smooth muscle alpha-actin gene is a transcriptional target of the p53 tumor suppressor protein Oncogene 1998, 16:1299-1308. 10.1038/sj.onc.1201645 9546431
20. Ashburner M Ball CA Blake JA Botstein D Butler H Cherry JM Davis AP Dolinski K Dwight SS Eppig JT Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium Nat Genet 2000, 25:25-29. 10.1038/ 75556 10802651
21. Dennis G Jr Sherman BT Hosack DA Yang J Gao W Lane HC Lempicki RA DAVID: Database for Annotation, Visualization, and Integrated Discovery Genome Biol 2003, 4;P3. 10.1186/gb-2003-4-5-p3 12734009
22. Scherle P Behrens T Staudt LM Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes Proc Natl Acad Sci USA 1993, 90:7568-7572. 47183 8356058 10.1073/ pnas.90.16.7568
23. Lo WY Tsai MH Tsai Y Hua CH Tsai FJ Huang SY Tsai CH Lai CC Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis Clin Chim Acta 2006, 16889763.
24. Leffers H Nielsen MS Andersen AH Honoré B Madsen P Vandekerckhove J Celis JE Identification of two human Rho GDP dissociation inhibitor proteins whose overexpression leads to disruption of the actin cytoskeleton Exp Cell Res 1993, 209:165-174. 10.1006/excr.1993.1298 8262133
25. Still IH Vince P Cowell JK The third member of the transforming acidic coiled coil-containing gene family, TACC3, maps in 4p16, close to translocation breakpoints in multiple myeloma, and is upregulated in various cancer cell lines Genomics 1999, 58:165-170. 10.1006/ geno.1999.5829 10366448
26. Jung CK Jung JH Park GS Lee A Kang CS Lee KY Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer Pathol Int 2006, 56:503-509. 10.1111/j.1440-1827.2006.01998.x 16930330
27. Miyasaka Y Enomoto N Nagayama K Izumi N Marumo F Watanabe M Sato C Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization Br J Cancer 2001, 85:228-234. 10.1054/bjoc.2001.1901 11461082
28. Madsen P Rasmussen HH Leffers H Honoré B Celis JE Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins J Invest Dermatol 1992, 99:299-305. 10.1111/ 1523-1747.ep12616641 1512466
29. Munz M Zeidler R Gires O The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP Cancer Lett 2005, 225:151-157. 10.1016/j.canlet.2004.11.048 15922867
30. Schmidt M Schmidtke G Kloetzel PM Structure and structure formation of the 20S proteasome Mol Biol Rep 1997, 24:103-112. 10.1023/ A:1006826725056 9228290
31. Ogino T Shigyo H Ishii H Katayama A Miyokawa N Harabuchi Y Ferrone S HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker Cancer Res 2006, 66:9281-9289. 10.1158/0008-5472.CAN-06-0488 16982773
32. Meissner M Reichert TE Kunkel M Gooding W Whiteside TL Ferrone S Seliger B Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: Association with clinical outcome Clin Cancer Res 2005, 11:2552-2560. 10.1158/ 1078-0432.CCR-04-2146 15814633
33. Atkins D Ferrone S Schmahl GE Storkel S Seliger B Down-regulation of HLA class I antigen processing molecules: An immune escape mechanism of renal cell carcinoma? J Urol 2004, 171:885-889. 10.1097/ 01.ju.0000094807.95420.fe 14713847
34. Singal DP Ye M Ni J Snider DP Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines Immunol Lett 1996, 50:149-154. 10.1016/0165-2478(96)02531-X 8803612
35. Oettl K Stauber RE Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties Br J Pharmacol 2007, 151:580-590. 10.1038/sj.bjp.0707251 17471184
36. Wajih N Borras T Xue W Hutson SM Wallin R Processing and transport of matrix gamma-carboxyglutamic acid protein and bone morphogenetic protein-2 in cultured human vascular smooth muscle cells: Evidence for an uptake mechanism for serum fetuin J Biol Chem 2004, 279:43052-43060. 10.1074/jbc.M407180200 15280384
37. Boraldi F Annovi G Carraro F Naldini A Tiozzo R Sommer P Quaglino D Hypoxia influences the cellular cross-talk of human dermal fibroblasts. A proteomic approach Biochim Biophys Acta 2007, 1774:1402-1413. 17904921
38. Østergaard M Hansen GAW Vorum H Honoré B Proteomic profiling of fibroblasts reveals a modulating effect of extracellular calumenin on the organization of the actin cytoskeleton Proteomics 2006, 6:3509-3519. 10.1002/pmic.200500686 16691550
39. Perkins DN Pappin DJ Creasy DM Cottrell JS Probability-based protein identification by searching sequence databases using mass spectrometry data Electrophoresis 1999, 20:3551-3567. 10.1002/ (SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2 10612281